Emancro
2 known investors
Emancro builds AI-powered robots that automate hospital logistics tasks, starting with medication cabinet restocking.
Also known as EASO · GEDIA
Investors · 2
Company profile
researched Aug 2026Emancro develops general-purpose robots for healthcare logistics. Its product, EASO, is an AI-powered robot designed to automate hospital logistics work, beginning with medication distribution and the restocking of medication cabinets. The robot is described as able to pick and handle items, visually identify and correct misplaced items, pull bins from shelves, count items and open drawers, allowing pharmacy staff to offload repetitive and time-consuming tasks.
The company frames hospital logistics as a starting point rather than an end market: it positions hospitals as semi-structured environments with clear task definitions and enough diversity to train broadly capable robots, and names retail and warehouse restocking, industrial kitting and small-part sorting, and household tasks such as bed making as adjacent applications for the same capabilities. The team is described as interdisciplinary, combining machine learning researchers, roboticists, software and electronics engineers, and clinicians.
Founding story
The company was founded in 2022 around the mission of empowering mankind through robotics, and began by researching healthcare logistics tasks that could be automated with its robotic technology before building a medication cabinet restocking prototype.
Business model
Emancro supplies robotic systems to hospitals for medication logistics tasks, with EASO stated as available for automating medication logistics including medication cabinet restocking. Commercial terms are not disclosed.
Traction
More than 35 pharmacy directors expressed interest after the 2022 prototype showing; the company completed a first hospital pilot in September 2025 and describes ongoing pilots with leading U.S. hospitals.
Latest developments
Emancro reports piloting EASO at a leading U.S. hospital in September 2025 and states that it is currently piloting with leading U.S. hospitals, with EASO available for medication logistics automation including medication cabinet restocking.
▸Full profile — market position, technology, go-to-market, geography, history
Market position
Emancro positions itself as offering one of the first production-ready systems combining end-to-end visuomotor policies with traditional robotic planning and control, targeting hospital pharmacy automation as an entry point to general-purpose robotics.
Technology
Emancro's system, GEDIA (Generalizable Dexterous Intelligent Agent), integrates end-to-end visuomotor policies with conventional robotic planning and control, combining vision-language-action (VLA) models with geometric planning. The company states this allows handling of complex, long-duration tasks, continuous learning from experience, and instruction via natural language, user interfaces and APIs. The EASO robot platform has progressed to a dual-arm configuration with autonomous navigation and integrated barcode scanning.
Go-to-market
The company has used pharmacy industry trade shows, in particular the ASHP midyear clinical meetings from 2022 through 2024, to present successive versions of its robot to pharmacy directors, and is running pilots with U.S. hospitals.
Hospitals and hospital pharmacies, in particular pharmacy departments handling medication distribution and cabinet restocking; the company also identifies future applications in retail and warehousing, industry and manufacturing, and household tasks.
Geography
Emancro is listed at 1331 Seventh Street, Berkeley, California, and is associated with the Berkeley Startup Cluster. Pilots are being run with hospitals in the United States.
History
Emancro was founded in 2022. Between May and September 2022 it conducted market research in healthcare, visiting dozens of hospitals and speaking with more than 50 healthcare staff to identify logistics tasks suited to automation. Prototype development of a medication cabinet restocking robot began in October 2022, initially picking medication blisters with a single suction finger, and the prototype was shown at the ASHP 2022 midyear clinical meeting in Las Vegas. An enhanced EASO capable of autonomous navigation, retrieving medication trays from shelves and restocking medication items was presented at ASHP 2023, and the first dual-arm EASO, with higher speed and integrated barcode scanning, was presented at ASHP 2024. In September 2025 the company completed its first EASO pilot at a leading U.S. hospital.
Compiled by commissioned research from 8 cited public sources — announcements, filings, and press listed under research sources below.
Key figures
latest reportedCompany-reported or press-reported figures, each dated to when it was claimed — not independently audited.
Timeline · 5
launches, deals, and filingsEmancro completed a first pilot of the EASO robot at a leading hospital in the United States.
The first dual-arm version of EASO, presented at ASHP 2024, offered higher operating speeds and integrated barcode scanning.
An enhanced EASO version shown at ASHP 2023 could navigate autonomously, take a medication tray from a shelf and restock various medication items.
Emancro presented its robot prototype at the ASHP 2022 midyear clinical meeting in Las Vegas and reported interest from more than 35 pharmacy directors.
Emancro began developing a prototype robot for restocking medication cabinets; the early version picked medication blisters using a single suction finger.
Dated company events from announcements, filings, and press; legal rows summarize public dockets and regulator releases.
In the news
▸Research sources · 8
primary sources listed
- Emancro | Automating Hospital Logisticsemancro.ai · web
- Killed by AI — The AI Graveyard | 111 Dead AI Productsmixtpatrik.github.io · web
8 public sources were cited for this profile; the first-party ones are listed here.
Frequently asked questions
- What does Emancro do?
- Emancro builds AI-powered robots that automate hospital logistics tasks, starting with medication cabinet restocking.
- Who are Emancro's investors?
- Emancro's investors include AIX Ventures, Amplify Partners.